Sintx Technologies, Inc. (SINT) Stock

Sintx Technologies, Inc. (SINT) is a Healthcare stock trading at $2.22 (as of 2026-06-04), with a market capitalization of $8.39M and a trailing P/E of -0.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Sintx Technologies, Inc. (formerly Amedica Corporation) develops and commercializes medical devices and related advanced materials made with silicon nitride. It provides solid and porous silicon nitride, silicon nitrite powder, and silicon nitride coatings, along with composite materials and polyetherketoneketone for biomedical, industrial, and antipathogenic applications, primarily in the United States.

Valuation — source: SEC EDGAR (first-party)
Price	$2.22
Market Cap	$8.39M
P/E Ratio	-0.4
EV / EBITDA	-0.7
Price / Book	10.70
Price / Sales	9.40
DCF Value (model)	$-35.16
DCF Upside vs Price	-1683.8%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$1.02M
Net Margin	-1018.1%
Return on Equity	-1205.0%
Debt / Equity	0.12
Current Ratio	1.04
Revenue Growth (YoY)	-64.7%
EPS Growth (YoY)	-58.6%
FCF Growth (YoY)	-6.2%

Financial Health — source: SEC EDGAR
Altman Z-Score	-45.56 (distress)
Piotroski F-Score	3/9 (weak)

Valuation vs Sector & Industry
Stock P/E	-0.4
Sector P/E (Healthcare)	20.9
Industry P/E (Medical Equipment)	31.7
vs Sector	-101.9%
vs Industry	-101.3%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	Veracity Capital LLC ($191900.00)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Eric K. Olson
Employees	20
Country	US
IPO Date	2014-02-13

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-04.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.